Abstract
The study of the metastatic cascade has revealed the complexity of the process and the multiple cellular states that disseminated cancer cells must go through. The tumor microenvironment and in particular the extracellular matrix (ECM) plays an important role in regulating the transition from invasion, dormancy to ultimately proliferation during the metastatic cascade. The time delay from primary tumor detection to metastatic growth is regulated by a molecular program that maintains disseminated tumor cells in a non-proliferative, quiescence state known as tumor cell dormancy. Identifying dormant cells and their niches in vivo and how they transition to the proliferative state is an active area of investigation, and novel approaches have been developed to track dormant cells during dissemination. In this review, we highlight the latest research on the invasive nature of disseminated tumor cells and their link to dormancy programs. We also discuss the role of the ECM in sustaining dormant niches at distant sites.
Similar content being viewed by others
References
Massagué, J., & Obenauf, A. C. (2016). Metastatic colonization by circulating tumour cells. Nature, 529, 298–306.
Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19, 1423–1437.
Bravo-Cordero, J. J., Hodgson, L., & Condeelis, J. (2012). Directed cell invasion and migration during metastasis. Current Opinion in Cell Biology, 24, 277–283.
Ganesh, K., & Massagué, J. (2021). Targeting metastatic cancer. Nature Medicine, 27, 34–44.
Mondal, C., Di Martino, J. S., & Bravo-Cordero, J. J. (2021). Actin dynamics during tumor cell dissemination. International Review of Cell and Molecular Biology, 360, 65–98.
Hosseini, H., et al. (2016). Early dissemination seeds metastasis in breast cancer. Nature, 540, 552–558.
Werner-Klein, M., et al. (2018). Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma. Nature Communications, 9, 595.
Ray, A., et al. (2022). Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma. JCI Insight, 7.
Kai, F. B., Drain, A. P., & Weaver, V. M. (2019). The extracellular matrix modulates the metastatic journey. Developmental Cell, 49, 332–346.
Wang, J., & Kim, S. K. (2003). Global analysis of dauer gene expression in Caenorhabditis elegans. Development, 130, 1621–1634.
Koornneef, M., Bentsink, L., & Hilhorst, H. (2002). Seed dormancy and germination. Current Opinion in Plant Biology, 5, 33–36.
Willis, R. A. (1934). The spread of tumours in the human body. J. A. Churchill.
Hadfield, G. (1954). The dormant cancer cell. British Medical Journal, 2, 607–610.
Worrall, R. (1954). The dormant cancer cell ( Correspondence). British Medical Journal, 2, 813.
Bryant, T. (1902). An analysis of forty-six cases of cancer of the breast which have been operated upon and survived the operation from 5 to 32 years, with remarks upon the treatment of recurrent growths, including the disease of the second breast, operative and otherwise. British Medical Journal, 1, 1200–1203.
Ashley, D. J. (1965). On the incidence of carcinoma of the prostate. The Journal of Pathology and Bacteriology, 90, 217–224.
Mortensen, J. D., Woolner, L. B., & Bennett, W. A. (1955). Gross and microscopic findings in clinically normal thyroid glands. The Journal of Clinical Endocrinology and Metabolism, 15, 1270–1280.
Beckwith, J. B., & Perrin, E. V. (1963). In situ neuroblastomas: A contribution to the natural history of neural crest tumors. The American Journal of Pathology, 43, 1089–1104.
Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995). Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine, 1, 149–153.
Townson, J. L., & Chambers, A. F. (2006). Dormancy of solitary metastatic cells. Cell Cycle, 5, 1744–1750.
Yeh, A. C., & Ramaswamy, S. (2015). Mechanisms of cancer cell dormancy --Another hallmark of cancer? Cancer Research, 75, 5014–5022.
Phan, T. G., & Croucher, P. I. (2020). The dormant cancer cell life cycle. Nature Reviews. Cancer, 20, 398–411.
Naumov, G. N., Folkman, J., & Straume, O. (2009). Tumor dormancy due to failure of angiogenesis: Role of the microenvironment. Clinical & Experimental Metastasis, 26, 51–60.
Naumov, G. N., Akslen, L. A., & Folkman, J. (2006). Role of angiogenesis in human tumor dormancy: Animal models of the angiogenic switch. Cell Cycle, 5, 1779–1787.
Almog, N., et al. (2006). Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis. FASEB Journal, 20, 947–949.
Senft, D., & Ronai, Z. A. (2016). Immunogenic, cellular, and angiogenic drivers of tumor dormancy--A melanoma view. Pigment Cell & Melanoma Research, 29, 27–42.
Shchors, K., et al. (2006). The Myc-dependent angiogenic switch in tumors is mediated by interleukin 1beta. Genes & Development, 20, 2527–2538.
Stockmann, C., Schadendorf, D., Klose, R., & Helfrich, I. (2014). The impact of the immune system on tumor: Angiogenesis and vascular remodeling. Frontiers in Oncology, 4, 69.
Koebel, C. M., et al. (2007). Adaptive immunity maintains occult cancer in an equilibrium state. Nature, 450, 903–907.
Schaller, J., & Agudo, J. (2020). Metastatic colonization: Escaping immune surveillance. Cancers (Basel), 12.
Ghajar, C. M. (2015). Metastasis prevention by targeting the dormant niche. Nature Reviews Cancer, 15(4), 238–247. https://doi.org/10.1038/nrc3910
Mohme, M., Riethdorf, S., & Pantel, K. (2017). Circulating and disseminated tumour cells - Mechanisms of immune surveillance and escape. Nature Reviews Clinical Oncology, 14, 155–167.
Salmon, H., et al. (2016). Expansion and activation of CD103+dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity, 44, 924–938.
Mahnke, Y. D., Schwendemann, J., Beckhove, P., & Schirrmacher, V. (2005). Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells. Immunology, 115, 325–336.
Müller-Hermelink, N., et al. (2008). TNFR1 signaling and IFN-gamma signaling determine whether T cells induce tumor dormancy or promote multistage carcinogenesis. Cancer Cell, 13, 507–518.
Wang, H.-F., et al. (2019). Targeting immune-mediated dormancy: A promising treatment of cancer. Frontiers in Oncology, 9, 498.
Linde, N., Fluegen, G., & Aguirre-Ghiso, J. A. (2016). The relationship between dormant cancer cells and their microenvironment. Advances in Cancer Research, 132.
Risson, E., Nobre, A. R., Maguer-Satta, V., & Aguirre-Ghiso, J. A. (2020). The current paradigm and challenges ahead for the dormancy of disseminated tumor cells. Nature Cancer, 1, 672–680.
Raviraj, V., et al. (2012). Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas. Clinical & Experimental Metastasis, 29, 273–292.
Bayarmagnai, B., et al. (2019). Invadopodia-mediated ECM degradation is enhanced in the G1 phase of the cell cycle. Journal of Cell Science, 132.
Ruppender, N., et al. (2015). Cellular adhesion promotes prostate cancer cells escape from dormancy. PLoS One, 10, e0130565.
Borgen, E., et al. (2018). NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients. Breast Cancer Research, 20, 120.
Harper, K. L., et al. (2016). Mechanism of early dissemination and metastasis in Her2+mammary cancer. Nature, 540(7634), 588–592. https://doi.org/10.1038/nature20609
Fluegen, G., et al. (2017). Phenotypic heterogeneity of disseminated tumour cells is preset by primary tumour hypoxic microenvironments. Nature Cell Biology, 19(2), 120–132. https://doi.org/10.1038/ncb3465
Borriello, L., et al. (2022). Primary tumor associated macrophages activate programs of invasion and dormancy in disseminating tumor cells. Nature Communications, 13, 626.
Harney, A. S., et al. (2015). Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discovery, 5, 932–943.
Pignatelli, J., et al. (2014). Invasive breast carcinoma cells from patients exhibit MenaINV- and macrophage-dependent transendothelial migration. Science Signaling, 7, ra112.
Rohan, T. E., et al. (2014). Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer. Journal of the National Cancer Institute, 106.
Mondal, C., et al. (2022). A proliferative to invasive switch is mediated by srGAP1 downregulation through the activation of TGF-β2 signaling. Cell Reports, 40, 111358.
Kienast, Y., et al. (2010). Real-time imaging reveals the single steps of brain metastasis formation. Nature Medicine, 16, 116–122.
Price, T. T., et al. (2016). Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aad4059
Gundem, G., et al. (2015). The evolutionary history of lethal metastatic prostate cancer. Nature, 520, 353–357.
Hong, M. K. H., et al. (2015). Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer. Nature Communications, 6, 6605.
Krøigård, A. B., et al. (2017). Genomic analyses of breast cancer progression reveal distinct routes of metastasis emergence. Scientific Reports, 7, 43813.
Schwarz, R. F., et al. (2015). Spatial and temporal heterogeneity in high-grade serous ovarian cancer: A phylogenetic analysis. PLoS Medicine, 12, e1001789.
Hoover, H. C. J., & Ketcham, A. S. (1975). Metastasis of metastases. American Journal of Surgery, 130, 405–411.
Hart, I. R., & Fidler, I. J. (1980). Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer Research, 40, 2281–2287.
Strauss, D. C., & Thomas, J. M. (2010). Transmission of donor melanoma by organ transplantation. The Lancet Oncology, 11, 790–796.
Stephens, J. K., et al. (2000). Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation, 70, 232–236.
Borriello, L., Condeelis, J., Entenberg, D., & Oktay, M. H. (2021). Breast cancer cell re-dissemination from lung metastases-A mechanism for enhancing metastatic burden. Journal of Clinical Medicine, 10.
Condeelis, J. S., & Entenberg, D. (2020). Hematogenous dissemination of breast cancer cells from lymph nodes is mediated by tumor microenvironment of metastasis doorways. Frontiers in Oncology, 10, 1–9.
Pereira, E. R., et al. (2018). Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science, 359, 1403–1407.
Brown, M., et al. (2018). Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science, 359, 1408–1411.
Bragado, P., et al. (2013). TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling. Nature Cell Biology, 15(11), 1351–1361. https://doi.org/10.1038/ncb2861
Nobre, A. R., et al. (2021). Bone marrow NG2(+)/Nestin(+) mesenchymal stem cells drive DTC dormancy via TGFβ2. Nature Cancer, 2, 327–339.
Zhang, W., et al. (2021). The bone microenvironment invigorates metastatic seeds for further dissemination. Cell, 184, 2471–2486.e20.
Baccelli, I., et al. (2013). Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nature Biotechnology, 31, 539–544.
Nemec, S., & Kilian, K. A. (2021). Materials control of the epigenetics underlying cell plasticity. Nature Reviews Materials, 6, 69–83.
Dai, J., et al. (2022). Astrocytic laminin-211 drives disseminated breast tumor cell dormancy in brain. Nature Cancer, 3, 25–42.
Nallanthighal, S., Heiserman, J. P., & Cheon, D.-J. (2019). The role of the extracellular matrix in cancer stemness. Frontiers in Cell and Development Biology, 7, 86.
Barney, L. E., et al. (2020). Tumor cell-organized fibronectin maintenance of a dormant breast cancer population. Science Advances, 6, eaaz4157.
Karamanos, N. K., et al. (2021). A guide to the composition and functions of the extracellular matrix. The FEBS Journal, 288, 6850–6912.
Sun, Z., Guo, S. S., & Fässler, R. (2016). Integrin-mediated mechanotransduction. The Journal of Cell Biology, 215, 445–456.
Wolfenson, H., Yang, B., & Sheetz, M. P. (2019). Steps in mechanotransduction pathways that control cell morphology. Annual Review of Physiology, 81, 585–605.
Kechagia, J. Z., Ivaska, J., & Roca-Cusachs, P. (2019). Integrins as biomechanical sensors of the microenvironment. Nature Reviews. Molecular Cell Biology, 20, 457–473.
Burridge, K., Monaghan-Benson, E., & Graham, D. M. (2019). Mechanotransduction: From the cell surface to the nucleus via RhoA. Philosophical Transactions of the Royal Society B, 374, 20180229.
Ohashi, K., Fujiwara, S., & Mizuno, K. (2017). Roles of the cytoskeleton, cell adhesion and rho signalling in mechanosensing and mechanotransduction. Journal of Biochemistry, 161, 245–254.
Coste, B., et al. (2010). Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science, 330, 55–60.
Wang, Y., & Xiao, B. (2018). The mechanosensitive Piezo1 channel: Structural features and molecular bases underlying its ion permeation and mechanotransduction. The Journal of Physiology, 596, 969–978.
Geng, J., et al. (2020). A plug-and-latch mechanism for gating the mechanosensitive Piezo Channel. Neuron, 106, 438–451.e6.
Qin, L., et al. (2021). Roles of mechanosensitive channel Piezo1/2 proteins in skeleton and other tissues. Bone Research, 9, 44.
Pathak, M. M., et al. (2014). Stretch-activated ion channel Piezo1 directs lineage choice in human neural stem cells. Proceedings of the National Academy of Sciences of the United States of America, 111, 16148–16153.
Sun, X., et al. (2021). Bone piezoelectricity-mimicking nanocomposite membranes enhance osteogenic differentiation of bone marrow mesenchymal stem cells by amplifying cell adhesion and actin cytoskeleton. Journal of Biomedical Nanotechnology, 17, 1058–1067.
Wang, F., et al. (2017). Mechanosensitive ion channel Piezo2 is important for enterochromaffin cell response to mechanical forces. The Journal of Physiology, 595, 79–91.
Lai, A., et al. (2022). Mechanosensing by Piezo1 and its implications for physiology and various pathologies. Biological Reviews of the Cambridge Philosophical Society, 97, 604–614.
Wu, J., Lewis, A. H., & Grandl, J. (2017). Touch, tension, and transduction - The function and regulation of Piezo ion channels. Trends in Biochemical Sciences, 42, 57–71.
Kenmochi, M., et al. (2022). Involvement of mechano-sensitive Piezo1 channel in the differentiation of brown adipocytes. The Journal of Physiological Sciences, 72, 13.
Wang, N., Tytell, J. D., & Ingber, D. E. (2009). Mechanotransduction at a distance: Mechanically coupling the extracellular matrix with the nucleus. Nature Reviews. Molecular Cell Biology, 10, 75–82.
Bouzid, T., et al. (2019). The LINC complex, mechanotransduction, and mesenchymal stem cell function and fate. Journal of Biological Engineering, 13, 68.
Kalukula, Y., Stephens, A. D., Lammerding, J., & Gabriele, S. (2022). Mechanics and functional consequences of nuclear deformations. Nature Reviews. Molecular Cell Biology, 23, 583–602.
Hamouda, M. S., Labouesse, C., & Chalut, K. J. (2020). Nuclear mechanotransduction in stem cells. Current Opinion in Cell Biology, 64, 97–104.
Alam, S. G., et al. (2016). The mammalian LINC complex regulates genome transcriptional responses to substrate rigidity. Scientific Reports, 6, 38063.
Chang, W., Worman, H. J., & Gundersen, G. G. (2015). Accessorizing and anchoring the LINC complex for multifunctionality. The Journal of Cell Biology, 208, 11–22.
Sharili, A. S., & Connelly, J. T. (2014). Nucleocytoplasmic shuttling: A common theme in mechanotransduction. Biochemical Society Transactions, 42, 645–649.
Kofler, M., & Kapus, A. (2021). Nucleocytoplasmic shuttling of the mechanosensitive transcription factors MRTF and YAP /TAZ. Methods in Molecular Biology, 2299, 197–216.
Jang, J.-W., Kim, M.-K., & Bae, S.-C. (2020). Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway. Small GTPases, 11, 280–288.
Miranda, M. Z., Lichner, Z., Szászi, K., & Kapus, A. (2021). MRTF: Basic biology and role in kidney disease. International Journal of Molecular Sciences, 22.
Shreberk-Shaked, M., & Oren, M. (2019). New insights into YAP/TAZ nucleo-cytoplasmic shuttling: New cancer therapeutic opportunities? Molecular Oncology, 13, 1335–1341.
Speight, P., Kofler, M., Szászi, K., & Kapus, A. (2016). Context-dependent switch in chemo/mechanotransduction via multilevel crosstalk among cytoskeleton-regulated MRTF and TAZ and TGFβ-regulated Smad3. Nature Communications, 7, 11642.
Er, E. E., et al. (2018). Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nature Cell Biology, 20, 966–978.
Tello-Lafoz, M., et al. (2021). Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer. Immunity, 54, 1037–1054.e7.
Zabransky, D. J., Jaffee, E. M., & Weeraratna, A. T. (2022). Shared genetic and epigenetic changes link aging and cancer. Trends in Cell Biology, 32, 338–350.
Naik, S., & Fuchs, E. (2022). Inflammatory memory and tissue adaptation in sickness and in health. Nature, 607, 249–255.
Skvortsova, K., Stirzaker, C., & Taberlay, P. (2019). The DNA methylation landscape in cancer. Essays in Biochemistry, 63, 797–811.
Dawson, M. A., & Kouzarides, T. (2012). Cancer epigenetics: From mechanism to therapy. Cell, 150, 12–27.
Stowers, R., & Chaudhuri, O. (2021). Epigenetic regulation of mechanotransduction. Nature Biomedical Engineering, 5, 8–10.
Stowers, R. S., et al. (2019). Matrix stiffness induces a tumorigenic phenotype in mammary epithelium through changes in chromatin accessibility. Nature Biomedical Engineering, 3, 1009–1019.
Jang, M., et al. (2021). Matrix stiffness epigenetically regulates the oncogenic activation of the Yes-associated protein in gastric cancer. Nature Biomedical Engineering, 5, 114–123.
Gupta, V. K., & Chaudhuri, O. (2022). Mechanical regulation of cell-cycle progression and division. Trends in Cell Biology, 32, 773–785.
Sosa, M. S., et al. (2015). NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes. Nature Communications, 6, 6170.
Singh, D. K., et al. (2021). Epigenetic reprogramming of DCCs into dormancy suppresses metastasis <em>via</em> restored TGFβ–SMAD4 signaling. https://arxiv.org/abs/2021.08.01.454684. https://doi.org/10.1101/2021.08.01.454684
Liu, Y., et al. (2018). 3D Fibrin stiffness mediates dormancy of tumor-repopulating cells via a Cdc42-driven Tet2 epigenetic program. Cancer Research, 78(14), 3926–3937. https://doi.org/10.1158/0008-5472.CAN-17-3719
Schofield, R. (1978). The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells, 4, 7–25.
Socovich, A. M., & Naba, A. (2019). The cancer matrisome: From comprehensive characterization to biomarker discovery. Seminars in Cell and Developmental Biology, 89. https://doi.org/10.1016/j.semcdb.2018.06.005
Naba, A., et al. (2012). The matrisome: In silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Molecular & Cellular Proteomics, 11, M111.014647-M111.014647.
Hynes, R. O., & Naba, A. (2012). Overview of the matrisome--An inventory of extracellular matrix constituents and functions. Cold Spring Harbor Perspectives in Biology, 4, a004903.
Aguirre-Ghiso, J. A., Liu, D., Mignatti, A., Kovalski, K., & Ossowski, L. (2001). Urokinase receptor and fibronectin regulate the ERKMAPK to p38MAPK activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Molecular Biology of the Cell, 12(4), 863–879. https://doi.org/10.1091/mbc.12.4.863
Aguirre Ghiso, J. A., Kovalski, K., & Ossowski, L. (1999). Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. The Journal of Cell Biology, 147, 89–103.
Di Martino, J. S., et al. (2022). A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy. Nature Cancer, 3, 90–107.
Montagner, M., et al. (2020). Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination. Nature Cell Biology, 22, 289–296.
Nobre, A. R., et al. (2022). ZFP281 drives a mesenchymal-like dormancy program in early disseminated breast cancer cells that prevents metastatic outgrowth in the lung. Nature Cancer, 3(10), 1165–1180. https://doi.org/10.1038/s43018-022-00424-8
Aouad, P., et al. (2022). Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence. Nature Communications, 13, 4975.
Coppock, D. L., Kopman, C., Scandalis, S., & Gilleran, S. (1993). Preferential gene expression in quiescent human lung fibroblasts. Cell Growth and Differentiation, 4, 483–493.
Barkan, D., et al. (2010). Metastatic growth from dormant cells induced by a Col-I-enriched fibrotic environment. Cancer Research, 70, 5706–5716.
Ohta, Y., et al. (2022). Cell-matrix interface regulates dormancy in human colon cancer stem cells. Nature, 608, 784–794.
Albrengues, J., et al. (2018). Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science, 361(6409), eaao4227.
Ghajar, C. M., et al. (2013). The perivascular niche regulates breast tumour dormancy. Nature Cell Biology, 15, 807–817.
Fane, M. E., et al. (2022). Stromal changes in the aged lung induce an emergence from melanoma dormancy. Nature, 606, 396–405.
Elkholi, I. E., Lalonde, A., Park, M., & Côté, J.-F. (2022). Breast cancer metastatic dormancy and relapse: An enigma of microenvironment(s). Cancer Research, 82, 4497–4510.
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014). Mechanisms of disseminated cancer cell dormancy: An awakening field. Nature Reviews Cancer, 14, 611–622.
Russo, S., Scotto di Carlo, F., & Gianfrancesco, F. (2022). The osteoclast traces the route to bone tumors and metastases. Frontiers in Cell and Development Biology, 10, 886305.
Heyn, C., et al. (2006). In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain. Magnetic Resonance in Medicine, 56, 1001–1010.
Heyn, C., et al. (2006). In vivo magnetic resonance imaging of single cells in mouse brain with optical validation. Magnetic Resonance in Medicine, 55, 23–29.
Shapiro, E. M., Sharer, K., Skrtic, S., & Koretsky, A. P. (2006). In vivo detection of single cells by MRI. Magnetic Resonance in Medicine, 55, 242–249.
Di Martino, J. S., Mondal, C., & Bravo-Cordero, J. J. (2019). Textures of the tumour microenvironment. Essays in Biochemistry, 63, 619–629.
Fukumura, D., Duda, D. G., Munn, L. L., & Jain, R. K. (2010). Tumor microvasculature and microenvironment: Novel insights through intravital imaging in pre-clinical models. Microcirculation, 17, 206–225.
Fisher, D. T., et al. (2016). Intraoperative intravital microscopy permits the study of human tumour vessels. Nature Communications, 7, 10684.
Moore, N., & Lyle, S. (2011). Quiescent, slow-cycling stem cell populations in cancer: A review of the evidence and discussion of significance. Journal of Oncology, 2011.
Cotsarelis, G., Sun, T. T., & Lavker, R. M. (1990). Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell, 61, 1329–1337.
Potten, C. S., Kellett, M., Roberts, S. A., Rew, D. A., & Wilson, G. D. (1992). Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. Gut, 33, 71–78.
Schillert, A., Trumpp, A., & Sprick, M. R. (2013). Label retaining cells in cancer--The dormant root of evil? Cancer Letters, 341, 73–79.
Aguirre-Ghiso, J. A., Ossowski, L., & Rosenbaum, S. K. (2004). Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Research, 64, 7336–7345.
Regot, S., Hughey, J. J., Bajar, B. T., Carrasco, S., & Covert, M. W. (2014). High-sensitivity measurements of multiple kinase activities in live single cells. Cell, 157, 1724–1734.
Yano, S., Tazawa, H., Kagawa, S., Fujiwara, T., & Hoffman, R. M. (2020). FUCCI Real-time cell-cycle imaging as a guide for designing improved cancer therapy: A review of innovative strategies to target quiescent chemo-resistant cancer cells. Cancers (Basel), 12.
Sakaue-Sawano, A., & Miyawaki, A. (2014). Visualizing spatiotemporal dynamics of multicellular cell-cycle progressions with fucci technology. Cold Spring Harbor Protocols, 2014.
Sakaue-Sawano, A., et al. (2008). Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell, 132, 487–498.
Oki, T., et al. (2014). A novel cell-cycle-indicator, mVenus-p27K-, identifies quiescent cells and visualizes G0-G1 transition. Scientific Reports, 4, 4012.
Spencer, S. L., et al. (2013). XThe proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit. Cell, 155, 369–383.
Freter, R., et al. (2021). Establishment of a fluorescent reporter of RNA-polymerase II activity to identify dormant cells. Nature Communications, 12, 3318.
Owen, K. L., et al. (2020). Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone. EMBO Reports, 21, e50162.
Khoo, W. H., et al. (2019). A niche-dependent myeloid transcriptome signature defines dormant myeloma cells. Blood, 134, 30–43.
Ren, Q., et al. (2022). Gene expression predicts dormant metastatic breast cancer cell phenotype. Breast Cancer Research, 24, 10.
Aguirre-Ghiso, J. A. (2021). Translating the science of cancer dormancy to the clinic. Cancer Research, 81, 4673–4675.
Pranzini, E., Raugei, G., & Taddei, M. L. (2022). Metabolic features of tumor dormancy: Possible therapeutic strategies. Cancers (Basel), 14.
Garcia-Recio, S., et al. (2022). Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nature Cancer. https://doi.org/10.1038/s43018-022-00491-x
Tan, Z., et al. (2022). Mapping breast cancer microenvironment through single-cell omics. Frontiers in Immunology, 13, 868813.
Ma, R.-Y., Black, A., & Qian, B.-Z. (2022). Macrophage diversity in cancer revisited in the era of single-cell omics. Trends in Immunology, 43, 546–563.
Funding
This work was supported by NCI R01 (CA244780), NCI R03 (CA270679), the Irma T. Hirschl Trust, the Emerging Leader Award from the Mark Foundation (to J. J .B. C), and the Tisch Cancer Institute NIH Cancer Center grant (P30 CA196521).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Mukherjee, A., Bravo-Cordero, J.J. Regulation of dormancy during tumor dissemination: the role of the ECM. Cancer Metastasis Rev 42, 99–112 (2023). https://doi.org/10.1007/s10555-023-10094-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-023-10094-2